Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris (ReGenHeart)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03039751
Recruitment Status : Not yet recruiting
First Posted : February 1, 2017
Last Update Posted : September 21, 2018
Queen Mary University of London
University College, London
Medical University of Vienna
Servicio Madrileño de Salud, Madrid, Spain
FinVector Vision Therapies Oy
Śląski Uniwersytet Medyczny w Katowicach
Rigshospitalet, Denmark
Euram Limited
Information provided by (Responsible Party):
Kuopio University Hospital

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2021